Preparing for Crew-Control of Surface Robots from Orbit

Since 2010, the European Space Agency (ESA) and the National Aeronautics and Space Administration (NASA) have been developing robots that can be remotely operated on planetary surfaces by astronauts in orbiting spacecraft. A primary objective of this work has been to test telerobotic technologies that are needed for future deep-space human exploration missions. Specifically, ESA's Multi-Purpose End-To-End Robotic Operations Network (METERON) project and NASA's Human Exploration Telerobotics (HET) project are complementary initiatives that aim to validate communications, operations and robotic systems through a range of ground and flight experiments with humans and robots in the loop. Several experiments have already been successfully completed and others are now in preparation for flight

METERON Analog-1: A Touch Remote

The METERON project (Multipurpose End-To-End Robotics Operations Network) was implemented by the European Space Agency as an initiative to prepare Europe for future humanrobotic exploration scenarios that in particular, focused on examination of the human-robotic partnership, and how this partnership could be optimized through an evaluation of the tools and methodologies utilized in the experiments in the domains of operations, communications and robotics (specifically with respect to control strategies)

Telerobotic Operations with Time Delay, Results from the ISECG GAP Assesment Team

Since the Global Exploration Roadmap has been released in the third generation early this year, the International Space Exploration Coordination Group (ISECG) has formed two technology working groups (TWG) to identify gaps in “Telerobotic Operations with Time Delay” and “Autonomy Operations”, required by the mission profiles discussed in the Global Exploration Roadmap. This paper describes the compressed results from the Working Group “Telerobotic Operations with Time Delay”, including the goal and objectives of the working team. It gives an overview of the different mode of operation, required to control robots remotely. Analysing the mission scenarios described in the roadmap, the required robotic tasks has been extracted and gaps within those have been identified. These gaps are discussed respect to the common capabilities, divided and classified in operational, performance technology and non-technical gaps

Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status

Roux-en-Y gastric bypass (RYGB) surgery has negative effects on bone, mediated in part by effects on nutrient absorption. Not only can RYGB result in vitamin D malabsorption, but the bypassed duodenum and proximal jejunum are also the predominant sites of active, transcellular, 1,25(OH)(2)D-mediated calcium (Ca) uptake. However, Ca absorption occurs throughout the intestine, and those who undergo RYGB might maintain sufficient Ca absorption, particularly if vitamin D status and Ca intake are robust. We determined the effects of RYGB on intestinal fractional Ca absorption (FCA) while maintaining ample 25OHD levels (goal ≥30 ng/mL) and Ca intake (1200 mg daily) in a prospective cohort of 33 obese adults (BMI 44.7 ± 7.4 kg/m(2)). FCA was measured preoperatively and 6 months postoperatively with a dual stable isotope method. Other measures included calciotropic hormones, bone turnover markers, and BMD by DXA and QCT. Mean 6-month weight loss was 32.5 ± 8.4 kg (25.8% ± 5.2% of preoperative weight). FCA decreased from 32.7% ± 14.0% preoperatively to 6.9% ± 3.8% postoperatively (p < 0.0001), despite median (interquartile range) 25OHD levels of 41.0 (33.1 to 48.5) and 36.5 (28.8 to 40.4) ng/mL, respectively. Consistent with the FCA decline, 24-hour urinary Ca decreased, PTH increased, and 1,25(OH)(2)D increased (p ≤ 0.02). Bone turnover markers increased markedly, areal BMD decreased at the proximal femur, and volumetric BMD decreased at the spine (p < 0.001). Those with lower postoperative FCA had greater increases in serum CTx (ρ = −0.43, p = 0.01). Declines in FCA and BMD were not correlated over the 6 months. In conclusion, FCA decreased dramatically after RYGB, even with most 25OHD levels ≥30 ng/mL and with recommended Ca intake. RYGB patients may need high Ca intake to prevent perturbations in Ca homeostasis, although the approach to Ca supplementation needs further study. Decline in FCA could contribute to the decline in BMD after RYGB, and strategies to avoid long-term skeletal consequences should be investigated